Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 17:06:20
251,65 DKK
Kurs
Kurs
-0,24%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 245 | 251,65 | 245 | 2,642559 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 245 | 251,65 | 245 | 2,642559 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 251,65 305 | 251,65 | 305 | 21,200079 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 251,65 285 | 251,65 | 285 | 13,252533 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 251,65 260 | 251,65 | 260 | 3,318101 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 265 | 251,65 | 265 | 5,304987 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 251,65 300 | 251,65 | 300 | 19,213193 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 265 | 251,65 | 265 | 5,304987 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 265 | 251,65 | 265 | 5,304987 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 251,65 305 | 251,65 | 305 | 21,200079 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 251,65 | 251,65 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 251,65 285 | 251,65 | 285 | 13,252533 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 251,65 200 | 251,65 | 200 | 20,524538 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 251,65 310 | 251,65 | 310 | 23,186966 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 251,65 285 | 251,65 | 285 | 13,252533 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 251,65 285 | 251,65 | 285 | 13,252533 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 251,65 325 | 251,65 | 325 | 29,147626 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 251,65 305 | 251,65 | 305 | 21,200079 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 251,65 300 | 251,65 | 300 | 19,213193 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 251,65 175 | 251,65 | 175 | 30,458971 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 290 | 251,65 | 290 | 15,23942 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 251,65 | 251,65 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 251,65 300 | 251,65 | 300 | 19,213193 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 251,65 263 | 251,65 | 263 | 4,510232 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 251,65 175 | 251,65 | 175 | 30,458971 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 251,65 300 | 251,65 | 300 | 19,213193 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 251,65 263 | 251,65 | 263 | 4,510232 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 251,65 300 | 251,65 | 300 | 19,213193 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 251,65 260 | 251,65 | 260 | 3,318101 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 251,65 400 | 251,65 | 400 | 58,950924 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 251,65 400 | 251,65 | 400 | 58,950924 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 251,65 350 | 251,65 | 350 | 39,082058 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 251,65 250 | 251,65 | 250 | 0,655673 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 251,65 270 | 251,65 | 270 | 7,291874 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 251,65 340 | 251,65 | 340 | 35,108285 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 400 | 251,65 | 400 | 58,950924 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 251,65 275 | 251,65 | 275 | 9,27876 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 251,65 360 | 251,65 | 360 | 43,055832 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 251,65 360 | 251,65 | 360 | 43,055832 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 251,65 360 | 251,65 | 360 | 43,055832 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 251,65 350 | 251,65 | 350 | 39,082058 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 251,65 475 | 251,65 | 475 | 88,754222 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 251,65 332 | 251,65 | 332 | 31,929267 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 251,65 350 | 251,65 | 350 | 39,082058 | JPMORGAN |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M